What did @sarahbrandow actually say?
Sarah Brando, who identifies as a nutritionist employed by BioXcellerator, documented a week of treatments at the clinic she works for. She received what she called "my stem cells" via IV, hyperbaric oxygen therapy, dermatology procedures involving injections to the face, and multiple other IVs she described as part of her wellness week. She also received an "epigenetic consult" from a Dr. Valentina. Critically, she made no specific health claims about outcomes. She said "everything looked pretty good" from her epigenetic results and noted she "doesn't have any health issues." That last part matters. This is a wellness employee receiving employer treatments as a promotional experience, not a patient documenting a therapeutic outcome. The framing as patient-experience content, though, creates implicit trust that deserves scrutiny.
Does the science back this up?
The treatments shown span a wide spectrum of evidence quality, and lumping them together under "cutting-edge" obscures that gap considerably. Hyperbaric oxygen therapy (HBOT) has the strongest evidence base here. Systematic reviews, including Bhutani and Bhutani (2012, Undersea and Hyperbaric Medicine), support HBOT for wound healing and specific conditions like decompression sickness. Using it as a general wellness tool in healthy individuals is a different claim with much weaker support.
Intravenous stem cell therapy for healthy, non-diagnosed individuals is where the science gets uncomfortable. The FDA has repeatedly warned that unproven stem cell treatments carry real risks including infection, immune reactions, and tumor formation. A 2021 review by Marks et al. in the New England Journal of Medicine documented serious adverse events from unapproved stem cell products. The distinction between approved stem cell therapies (a narrow list) and what clinics like BioXcellerator offer is not a minor regulatory footnote. It is the entire clinical question.
"Epigenetic consults" as shown have essentially no peer-reviewed basis for clinical decision-making in healthy individuals at this time.
What did they get wrong (or right)?
To give credit where it is due: Sarah did not claim her treatments cured or treated anything. She has no stated health condition. She did not make before-and-after health comparisons. For a wellness influencer in this space, that restraint is worth acknowledging.
What she got wrong is harder to see but more important. The video normalizes IV stem cell therapy for healthy people as a routine wellness upgrade, the way you might talk about a massage or a sauna. That framing is doing a lot of work. The FDA's position is unambiguous: administering stem cell products outside of approved indications or clinical trials is illegal and carries documented patient risk. BioXcellerator operates in Colombia, which puts it outside FDA jurisdiction, but that does not make the treatments safer. It means there is less regulatory protection for the patient.
The "deep detox IVs" framing is also a red flag. The liver and kidneys handle detoxification. There is no peer-reviewed evidence that IV infusions "detox" a healthy body in any clinically meaningful way (Klein et al., 2007, Alternative Therapies in Health and Medicine).
What should you actually know?
If you are watching this video and thinking about booking a stem cell IV at a clinic abroad, here is what the research actually supports:
- Stem cell therapies approved by the FDA are limited to specific blood disorders and a small number of other conditions. General wellness applications are not among them.
- Medical tourism for stem cell treatment removes you from consumer protections that exist in regulated markets. A 2019 report in Cell Stem Cell (Turner and Knoepfler) identified over 700 U.S.-based and international businesses marketing unproven stem cell products.
- HBOT in a clinical setting has legitimate uses, but evidence for using it in healthy individuals for optimization is not strong enough to justify the cost or access barriers.
- "Epigenetic testing" for personalized health advice remains largely in research territory. Consumer-facing epigenetic age tests have not been validated as clinical diagnostic tools.
- The fact that a creator works for the company they are reviewing is a disclosure that should appear prominently, not buried in a caption. Viewers deserve to know the financial relationship upfront.